Flumazenil: potential implications for hepatic encephalopathy
Pharmacol Ther
.
1990;45(3):331-43.
doi: 10.1016/0163-7258(90)90070-i.
Authors
E A Jones
1
,
A S Basile
,
K D Mullen
,
S H Gammal
Affiliation
1
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
PMID:
2105510
DOI:
10.1016/0163-7258(90)90070-i
No abstract available
Publication types
Review
MeSH terms
Animals
Flumazenil / therapeutic use*
Hepatic Encephalopathy / drug therapy*
Humans
Substances
Flumazenil